Upfront nilotinib therapy among patients with chronic myeloid leukemia in chronic phase.

Upfront nilotinib therapy among patients with chronic myeloid leukemia in chronic phase.

Expert Opin Pharmacother. 2017 Jan 13;:

Authors: Eskazan AE

PMID: 28085518 [PubMed - as supplied by publisher]

http://ift.tt/2jIy7e9